Efficacy and safety analysis of Dupilumab for atopic dermatitis of all ages in Chinese population: Real-world data from a single center.
Allergy
; 79(5): 1379-1382, 2024 05.
Article
in En
| MEDLINE
| ID: mdl-38425152
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
/
Antibodies, Monoclonal, Humanized
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Allergy
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Denmark